Humoral and cellular immune responses to mRNA COVID-19 vaccines in patients with axial spondyloarthritis treated with adalimumab or secukinumab

Lancet Rheumatol. 2022 Mar;4(3):e163-e166. doi: 10.1016/S2665-9913(21)00393-3. Epub 2021 Dec 21.

Authors

Jitka Smetanova¹, Zuzana Strizova¹, Anna Sediva¹, Tomas Milota^{1

2}, Rudolf Horvath^{1

2}

Affiliations

¹ Department of Immunology, Second Faculty of Medicine Charles University and University Hospital Motol, Prague, 15006, Czech Republic.
² Department of Paediatric and Adult Rheumatology, University Hospital Motol, Prague, Czech Republic.

No abstract available